Archive — US — techcrunch
In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B
Abridge, an AI medical scribe startup, has doubled its valuation to $5.3 billion after a $300 million Series E funding round led by Andreessen Horowitz. The company, known for automating medical notes, has reported $117 million in annual recurring revenue and is expanding its services to convert appointment notes into AI medical codes, enhancing its competitive edge in the market.
Key points
- Abridge has secured $300 million in Series E funding, increasing its valuation from $2.75 billion to $5.3 billion in just four months.
- The funding round was led by Andreessen Horowitz with contributions from Khosla Ventures.
- Abridge has reached $117 million in annual recurring revenue, indicating strong customer contracts.
- The company is expanding services to convert patient appointment notes into AI medical codes, competing with other startups and leveraging its partnership with Epic Systems.
- Founded by cardiologist Shiv Rao, Abridge is currently utilized by over 150 major health systems in the U.S.
Why it matters
- The rise of AI in healthcare aligns with broader IT trends of automation and machine learning becoming integral in various sectors.
- Abridge's success reflects the growing investment and interest in health tech startups amid the ongoing digital transformation in healthcare, especially post-pandemic.
- The competitive landscape in AI medical scribes suggests a shift towards more efficient healthcare documentation practices in line with current trends of tech-enhanced patient care.
Abridge's rapid valuation growth and market expansion highlight the significant potential of AI in healthcare, setting a precedent for future innovations in medical documentation and efficiency.